Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
On March 27, 2023, Peter Thompson, M.D., a director of Janux Therapeutics, Inc.
(the "Company"), informed the Company that he does not intend to stand for
re-election as a member of the Board of Directors at the Company's 2023 annual
meeting of stockholders as a result of competing commitments. Dr. Thompson's
decision to not stand for re-election is not a result of any disagreement with
the Company on any matter relating to the Company's operations, policies or
practices.
1
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses